$429 Million Stem Cell/Gene Research Plan: New 'Preferences' for Determining Awards From California Agency
Late 'update' Monday of key document concerning the new criteria; no delineation of what was 'updated'
The California stem cell and genetic research agency subbed out a key document Monday afternoon in its $429 million plan to boost the impact of its effort to bring forth a revolutionary therapy to cure or treat deadly afflictions ranging from heart disease to the rare bubble baby syndrome.
The California Institute for Regenerative Medicine (CIRM), as the…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.